FDA
-
-
-
-
-
-
-
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
-
-
-
-
-
-
-
Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald on FDA Approval
-
-
-
-
-
-
-
Gilead and Lakefront complete $1.675 billion Ouro Medicines acquisition
-
-
-
-
-
-
-
FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
-
-
-
-
-
-
-
Gilead Sciences Announces First Quarter Financial Results
-
-
-
-
-
-
-
Galapagos enters partnership with Gilead for autoimmune drug development
-
-
-
-
-
-
-
Bernstein on Gilead Sciences (GILD) Post Arcellx Acquisition: 'We Like This Deal'
-
328,617 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

